Dementia Researcher Vodcast
Dementia Researcher Vodcast
Dementia Researcher
Rainwater Prize Winners: Advancing Tau Research
48 minutes Posted Mar 6, 2026 at 11:00 pm.
Introduction to the Rainwater Prize and Its Significance
Understanding Tau: The Central Protein in Neurodegeneration
The Role of Tau in Neurodegenerative Diseases
Exploring the Pathology of Tau and Its Variants
The Impact of Brain Banking on Neurodegenerative Research
Progressive Supranuclear Palsy: Symptoms and Pathology
Heterogeneity in Neurodegenerative Diseases
Therapeutics Targeting Tau Species
Mentorship and Leadership in Research
0:00
48:54
Download MP3
Show notes

In this episode, Professor Louise Serpell is joined by 2026 Rainwater Prize winners Professor Dennis Dickson, Professor Melissa Murray and Dr Marc Busche.

They talk about their work and the science that led to them earning this much deserved award, reflecting on decades of research into tau and its role in neurodegenerative disease. The conversation explores how tau functions in the healthy brain, how it becomes harmful in conditions such as Alzheimer’s disease and progressive supranuclear palsy, and why certain brain regions are especially vulnerable.

The discussion covers different forms of tau, including soluble species that may disrupt how neurons fire before visible tangles appear. Brain banking, imaging and fluid biomarkers are highlighted as key tools for understanding disease differences and improving diagnosis. The importance of rare MAPT mutations and what they can teach us about future treatments is also explored.

Alongside the science, there are thoughtful reflections on mentorship, risk taking and the value of asking ambitious questions in dementia research.

Key Takeaways

  • Tau is essential but context dependent. It is vital for normal brain function, yet changes in its chemistry, structure or location can drive neurodegeneration.
  • Tangles are not the whole story. Soluble tau species can disrupt neuronal firing, even in single cells, before visible aggregates appear.
  • Selective vulnerability defines tauopathies. Disorders such as PSP consistently affect specific brain regions & cell types, including glia, & we do not fully understand why.
  • One biomarker does not fit all. Tau PET and fluid markers behave differently across Alzheimer’s disease and primary tauopathies, reflecting structural differences in tau.
  • Progress depends on bold science. High risk experiments, strong mentorship and access to the right tools are essential for moving the field forward.

Find out more about the Rainwater Foundation:

https://rainwatercharitablefoundation.org/

--

A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.

If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.

Leave us a tip:

https://dementia-researcher.captivate.fm/support

Follow us on social media:


Download and Register with our Community App:

https://www.onelink.to/dementiaresearcher

We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.

The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.

Subscribe to our sister show 'Dementia Researcher The Blogs':

https://podfollow.com/dementia-researcher-blogs